Lebsack CS - Search Results

1

Clinical efficacy and electrophysiology of oral propafenone for ventricular tachycardia.

Connolly SJ, Kates RE, Lebsack CS, Echt DS, Mason JW, Winkle RA. Connolly SJ, et al. Among authors: lebsack cs. Am J Cardiol. 1983 Dec 1;52(10):1208-13. doi: 10.1016/0002-9149(83)90575-1. Am J Cardiol. 1983. PMID: 6359849 Clinical Trial.

2

Clinical pharmacology of intravenous enoximone: pharmacodynamics and pharmacokinetics in patients with heart failure.

Smith NA, Kates RE, Lebsack C, Ruder MA, Mead RH, Bekele T, Okerholm RA, Rubin GM, Winkle RA. Smith NA, et al. Am Heart J. 1991 Sep;122(3 Pt 1):755-63. doi: 10.1016/0002-8703(91)90522-j. Am Heart J. 1991. PMID: 1831585 Clinical Trial.

3

Disposition kinetics of orally administered enoximone in patients with moderate to severe heart failure.

Ruder MA, Lebsack C, Winkle RA, Mead RH, Smith N, Kates RE. Ruder MA, et al. J Clin Pharmacol. 1991 Aug;31(8):702-8. doi: 10.1002/j.1552-4604.1991.tb03763.x. J Clin Pharmacol. 1991. PMID: 1831816 Clinical Trial.

4

Pharmacodynamics of enoximone during intravenous infusion.

Winkle RA, Smith NA, Ruder MA, Mead RH, Lebsack C, Bekele T, Kates RE, Rubin J, Okerholm R. Winkle RA, et al. Int J Cardiol. 1990 Jul;28 Suppl 1:S1-2. doi: 10.1016/0167-5273(90)90142-r. Int J Cardiol. 1990. PMID: 2145232 Clinical Trial.

5

Clinical experience with sotalol in patients with drug-refractory ventricular arrhythmias.

Ruder MA, Ellis T, Lebsack C, Mead RH, Smith NA, Winkle RA. Ruder MA, et al. J Am Coll Cardiol. 1989 Jan;13(1):145-52. doi: 10.1016/0735-1097(89)90563-9. J Am Coll Cardiol. 1989. PMID: 2909562 Free article.

6

Ethmozine: electrophysiology, hemodynamics, and antiarrhythmic efficacy in patients with life-threatening ventricular arrhythmias.

Dorian P, Echt DS, Mead RH, Lee JT, Lebsack CS, Winkle RA. Dorian P, et al. Among authors: lebsack cs. Am Heart J. 1986 Aug;112(2):327-33. doi: 10.1016/0002-8703(86)90270-x. Am Heart J. 1986. PMID: 3526852

7

Propafenone disposition kinetics in cardiac arrhythmia.

Connolly S, Lebsack C, Winkle RA, Harrison DC, Kates RE. Connolly S, et al. Clin Pharmacol Ther. 1984 Aug;36(2):163-8. doi: 10.1038/clpt.1984.157. Clin Pharmacol Ther. 1984. PMID: 6744775

8

Clinical pharmacology of propafenone.

Connolly SJ, Kates RE, Lebsack CS, Harrison DC, Winkle RA. Connolly SJ, et al. Among authors: lebsack cs. Circulation. 1983 Sep;68(3):589-96. doi: 10.1161/01.cir.68.3.589. Circulation. 1983. PMID: 6872170 Clinical Trial.

9

Propafenone: a new antiarrhythmic agent.

Chow MS, Lebsack C, Hilleman D. Chow MS, et al. Clin Pharm. 1988 Dec;7(12):869-77. Clin Pharm. 1988. PMID: 3061720 Review.

10

Early ablation of newly diagnosed paroxysmal atrial fibrillation (NEWPaAF) versus newly diagnosed persistent atrial fibrillation (NEWPeAF): Comparison of patient populations and ablation outcomes.

Winkle RA, Hardwin Mead R, Engel G, Salcedo J, Brodt C, Barberini P, Lebsack C, Kong MH, Kalantarian S, Patrawala RA. Winkle RA, et al. J Cardiovasc Electrophysiol. 2024 May;35(5):984-993. doi: 10.1111/jce.16248. Epub 2024 Mar 14. J Cardiovasc Electrophysiol. 2024. PMID: 38486082

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

13 results

Search Page

Filters